A methodology to globally assess ectodomain shedding using soluble fractions from the mouse brain
Frontiers in Psychiatry · 19.06.2024 · 15
DOI: 10.3389/fpsyt.2024.1367526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 19.06.2024. Verfasst von Miguel Lobete und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Pharmacy, Instituto Universitario de Investigación en Neuroquímica, Universidad Compluten…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación.
Abstract (Originalsprache)
Ectodomain shedding (ES) is a fundamental process involving the proteolytic cleavage of membrane-bound proteins, leading to the release of soluble extracellular fragments (shed ectodomains) with potential paracrine and autocrine signaling functions. In the central nervous system (CNS), ES plays pivotal roles in brain development, axonal regulation, synapse formation, and disease pathogenesis, spanning from cancer to Alzheimer’s disease. Recent evidence also suggests its potential involvement in neurodevelopmental conditions like autism and schizophrenia. Past investigations of ES in the CNS have primarily relied on cell culture supernatants or cerebrospinal fluid (CSF) samples, but these methods have limitations, offering limited insights into how ES is modulated in the intact brain parenchyma. In this study, we introduce a methodology for analyzing shed ectodomains globally within rodent brain samples. Through biochemical tissue subcellular separation, mass spectrometry, and bioinformatic analysis, we show that the brain’s soluble fraction sheddome shares significant molecular and functional similarities with in vitro neuronal and CSF sheddomes. This approach provides a promising means of exploring ES dynamics in the CNS, allowing for the evaluation of ES at different developmental stages and pathophysiological states. This methodology has the potential to help us deepen our understanding of ES and its role in CNS function and pathology, offering new insights and opportunities for research in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Pharmacy, Instituto Universitario de Investigación en Neuroquímica, Universidad Complutense de Madrid, Madrid, Spain.
Förderung
- Agencia Estatal de Investigación
Zitieren
APA
Lobete, M., Salinas, T., Izquierdo-Bermejo, S., Socas, S., Oset-Gasque, M. J., & Martín-de-Saavedra, M. D. (2024). A methodology to globally assess ectodomain shedding using soluble fractions from the mouse brain. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1367526
Vancouver
Lobete M, Salinas T, Izquierdo-Bermejo S, Socas S, Oset-Gasque MJ, Martín-de-Saavedra MD. A methodology to globally assess ectodomain shedding using soluble fractions from the mouse brain. Frontiers in Psychiatry. 2024;15. doi:10.3389/fpsyt.2024.1367526
BibTeX
@article{Lobete2024,
author = {Lobete, Miguel and Salinas, Tamel and Izquierdo-Bermejo, Sara and Socas, Silvia and Oset-Gasque, María Jesús and Martín-de-Saavedra, M Dolores},
title = {A methodology to globally assess ectodomain shedding using soluble fractions from the mouse brain},
journal = {Frontiers in Psychiatry},
year = {2024},
volume = {15},
doi = {10.3389/fpsyt.2024.1367526}
}
EUVIMED